Alphagen Ltd Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 14942715

Alphagen Ltd

Filleted Unaudited Financial Statements

30 June 2025

Alphagen Ltd

Statement of Financial Position

30 June 2025

	2025	2024
Note	£	£

Fixed assets

Investments	4	201	–

Current assets

Debtors	5	827,652	711,830
Cash at bank and in hand		651	28,121
		---------	---------
		828,303	739,951

Creditors: amounts falling due within one year	6	832,546	740,534
		---------	---------
Net current liabilities		4,243	583
		-------	----
Total assets less current liabilities		( 4,042)	( 583)
		-------	----
Net liabilities		( 4,042)	( 583)
		-------	----

Capital and reserves

Called up share capital	850	850
Profit and loss account	( 4,892)	( 1,433)
	-------	-------
Shareholders deficit	( 4,042)	( 583)
	-------	-------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Alphagen Ltd

Statement of Financial Position (continued)

30 June 2025

These financial statements were approved by the board of directors and authorised for issue on 4 December 2025 , and are signed on behalf of the board by:

Mr J H Fearnall

Director

Company registration number: 14942715

Alphagen Ltd

Notes to the Financial Statements

Year ended 30 June 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 1 Dunston Place, Dunston Road, Chesterfield, S41 8NL.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.

Going concern

The Directors do not consider the Company to be a going concern. The Company is a holding company established for investment-holding purposes and does not carry out any trading activities. Its ongoing viability is dependent on the continued support of its shareholders and the value of its underlying investments. Accordingly, the financial statements have not been prepared on a going concern basis and the Shareholders have confirmed their ongoing investment.

Consolidation

The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

4. Investments

	Shares in group undertakings
	£
Cost
At 1 July 2024	–
Additions	201
	----
At 30 June 2025	201
	----
Impairment
At 1 July 2024 and 30 June 2025	–
	----

Carrying amount
At 30 June 2025	201
	----
At 30 June 2024	–
	----

5. Debtors

	2025	2024
	£	£
Other debtors	827,652	711,830
	---------	---------

6. Creditors: amounts falling due within one year

	2025	2024
	£	£
Hung Yuan Loan	828,510	738,922
Other creditors	4,036	1,612
	---------	---------
	832,546	740,534
	---------	---------

7. Directors' advances, credits and guarantees

In the year the directors operated loan accounts with the company. At the year end, the cumulative total owed to the directors by the company amounted to £2,699 (2024 £129).

8. Related party transactions

No one party has overall control of the company. At the year end a total balance of £828,016 (2024 £481,529) was due from entities which the company has significant influence over. No other transactions with related parties were undertaken such as are required to be disclosed under Section 33 of Financial Reporting Standard 102.